예시 분류1
Tesamorelin
- 2mg*10vials USD 41.00
- 5mg*10vials USD 80.00
- 10mg*10vials USD 160.00
- 20mg*10vials USD 248.00
참고가입니다. 결제 전에 컨시어지가 금액을 확인합니다.
5.0 / 5 · 2283 개주문을 보낸 뒤 컨시어지에게 연락할 때 주문 번호를 알려 주십시오.
제품 특징
FDA approves treatment specifically for reducing visceral fat
제품 소개
Tesamorelin is a synthetic 44-amino acid peptide analog that resembles growth hormone-releasing hormone (GHRH). It stimulates the release of endogenous growth hormone and increases IGF-1 levels, thereby promoting lipolysis and providing metabolic benefits. Tesamorelin has been approved by the FDA for the reduction of visceral adipose tissue in individuals with HIV-associated lipodystrophy.
주의사항
Reconstitution: Add 2.5 mL of bacteriostatic water to each 5 mg vial → concentration becomes 2.0 mg/mL
Standard daily dose: 2 mg (2000 mcg) once daily
Easy measurement: 1 unit = 0.01 mL = 20 mcg
사용 방법
1. Draw 2.5 mL of bacteriostatic water using a sterile syringe.
2. Inject slowly along the inner wall of the vial; avoid the formation of bubbles.
3. Gently swirl until dissolved (do not shake).
4. Label the vial and store refrigerated at 2–8°C, protected from light.
5. Once reconstituted with bacteriostatic water, use within 7 days.
보관 방법
Lyophilized: Store at 2–8°C
Reconstituted with bacteriostatic water: Store refrigerated at 2–8°C; use within 7 days
Do not freeze the reconstituted solution; avoid repeated freeze-thaw cycles
리뷰
5.0 / 5
2283 개
최근 100개를 표시합니다.
-
★★★★★
VXB•••••••9836
독일
2026-10-20 07:34
The address on the box was correct. The label matches the listing. No issues on arrival.
-
★★★★★
VXF•••••••1BF6
캐나다
2026-10-20 03:41
The box arrived in good shape. The seal was clean and unbroken. The experience was smooth.
-
★★★★★
VX8•••••••E951
영국
2026-10-19 23:48
The parcel was packed securely. The closure was clean. The whole order was tidy.
-
★★★★★
VX0•••••••D220
영국
2026-10-19 19:56
The delivery window was kept. The inner seal was intact. Pleased with how it was sent.
-
★★★★★
VXD•••••••847A
네덜란드
2026-10-19 16:03
Support confirmed the destination before dispatch. The order form and the parcel agreed. The experience was smooth.
-
★★★★★
VXB•••••••66D2
호주
2026-10-19 12:10
Support confirmed the destination before dispatch. The label was easy to read. The experience was smooth.
-
★★★★★
VX1•••••••FC9F
호주
2026-10-19 08:18
Shipping was straightforward. The vial matched the description. I had no follow-up questions.
-
★★★★★
VXA•••••••7BED
기타
2026-10-19 04:25
The carton was dry and closed. The cap was tight. The experience was smooth.
-
★★★★★
VXD•••••••CFE4
영국
2026-10-19 00:32
The order arrived complete. The spec line matches what I received. I had no follow-up questions.
-
★★★★★
VXC•••••••2B0C
한국
2026-10-18 20:40
Support confirmed the destination before dispatch. The label was easy to read. It arrived exactly as described.
구매자 리뷰
주문할 때 사용한 주문 번호와 전화번호를 입력하세요. 둘 다 이 상품이 포함된 주문과 일치해야 합니다.
다른 진열 상품
예시 분류1
Cagrilintide
Cagrilintide is a long-acting, acylated amylin analogue—a pancreatic hormone—designed for once-weekly subcutaneous injection. It activates central amylin receptors, promoting satiety, slowing gastric emptying, and reducing food intake. In Phase 2 and Phase 3 clinical trials, cagrilintide induced dose-dependent weight loss, with side effects primarily being gastrointestinal in nature.
참고가USD 113.00
예시 분류1
CJC-1295+IPA(CP10)
This formulation combines CJC-1295 (without DAC)—a modified growth hormone-releasing hormone (GHRH) analog—with Ipamorelin, a selective growth hormone secretagogue (GHS). CJC-1295 (without DAC) produces a sustained, dose-dependent increase in GH and IGF-1 levels, while Ipamorelin selectively stimulates GH release without increasing ACTH or cortisol.
참고가USD 116.00
예시 분류1
Retatrutide
Retatrutide is an investigational triple-receptor agonist peptide (targeting GLP-1, GIP, and glucagon receptors) currently under development for the treatment of obesity and type 2 diabetes. Phase II clinical trials have demonstrated significant weight loss, with patients in the high-dose group achieving a weight reduction of up to 24% over 48 weeks. This educational program outlines a once-weekly subcutaneous administration regimen, incorporating a gradual dose-escalation approach to minimize gastrointestinal side effects.
참고가USD 45.00
예시 분류1
Tirzepatide
Tirzepatide is a dual incretin receptor agonist composed of 39 amino acids. It activates both GLP-1 and GIP receptors, thereby enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite. With a half-life of approximately 5 days, it is convenient to administer via a once-weekly subcutaneous injection. Clinical trials have demonstrated that tirzepatide offers superior efficacy in terms of glycemic control and weight loss compared to selective GLP-1 receptor agonists.
참고가USD 40.00